Telix Pharmaceuticals Q2 2024 Revenue and Business Highlights, Guidance Upgrade
![]() |
MELBOURNE, Australia, July 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 30 June 2024 (Q2 2024).
Q2 2024 Financial Performance and Guidance Upgrade
The Company reports unaudited total revenue of approximately U...
Read more: Telix Pharmaceuticals Q2 2024 Revenue and Business Highlights, Guidance Upgrade





